Home › Funds › Palo Alto Investors LP › PTCT
Palo Alto Investors LP position in PTCT
PTC THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 875,349 shares of PTCT (PTC THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$56.7M, representing 8.44% of its reported portfolio and ranking #1 among its reported holdings. Palo Alto Investors LP has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's PTCT position evolved
Palo Alto Investors LP first disclosed a stake in PTCT in Q3 2024 at 264,469 shares (US$9.8M). The position peaked in Q2 2026 at 918,846 shares, worth US$75.0M. Across 9 filings, Palo Alto Investors LP increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 875,349 shares valued at US$56.7M — a reduction of -43,497 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2024 (shares rose 13% over the following quarter), a 112% increase in Q3 2025 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 264.47K | $9.81M | New |
| Q4 2024 | 386.41K | $17.44M | Add |
| Q1 2025 | 404.20K | $20.60M | Add |
| Q2 2025 | 406.47K | $19.85M | Add |
| Q3 2025 | 862.61K | $52.94M | Add |
| Q4 2025 | 903.92K | $68.66M | Add |
| Q1 2026 | 921.61K | $62.79M | Add |
| Q2 2026 | 918.85K | $74.95M | Hold |
| Q3 2026 | 875.35K | $56.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 41 other funds we track also report a position in PTCT — the largest reported positions include WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M), Hood River Capital Management LLC (US$113.8M), RTW INVESTMENTS, LP (US$104.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.70M sh · $174.86M · Q3 2026
- Hood River Capital Management LLC 1.76M sh · $113.77M · Q3 2026
- RTW INVESTMENTS, LP 1.62M sh · $104.67M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $97.17M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.30M sh · $84.05M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.24M sh · $80.11M · Q3 2026
- Parkman Healthcare Partners LLC 700.39K sh · $45.37M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held PTCT?
Palo Alto Investors LP has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Palo Alto Investors LP's current position in PTCT?
As of Q3 2026, Palo Alto Investors LP holds 875.35K shares of PTCT (PTC THERAPEUTICS INC), valued at $56.71M, representing 8.44% of its reported portfolio and ranking #1.
Has Palo Alto Investors LP been buying or selling PTCT?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in PTCT. The position peaked in Q2 2026 at 918.85K shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include WESTFIELD CAPITAL MANAGEMENT CO LP, Hood River Capital Management LLC, RTW INVESTMENTS, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.